Updated COVID-19 Vaccines Reduce Hospitalization Risk for Adults with Autoimmune Rheumatic Conditions

A new analysis of over 60,000 U.S. adults with autoimmune rheumatic conditions shows that those who received booster or updated COVID-19 vaccines (2023-2024) had significantly lower hospitalization rates compared to those with only initial vaccination or no vaccination. The study, published in Arthritis & Rheumatology, examined COVID-19 cases from December 2020 through August 2024. For patients with conditions like rheumatoid arthritis, lupus, and other autoimmune diseases, staying current with updated COVID-19 vaccines provides critical protection against severe illness. Healthcare providers recommend that adults with autoimmune rheumatic conditions discuss vaccination schedules with their rheumatologists to maintain optimal protection.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: September 9, 2026 at 10:01 AM



